Immunosuppressive therapy for severe aplastic anemia in children under the age of 3 years yields a high response rate: a North American collaborative study.

  • Post category:Uncategorized
  • Reading time:1 min read

The article examines outcomes of immunosuppressive therapy (IST) in very young children diagnosed with severe aplastic a...

Continue ReadingImmunosuppressive therapy for severe aplastic anemia in children under the age of 3 years yields a high response rate: a North American collaborative study.

The Role of Allogeneic Hematopoietic Cell Transplantation in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.

This review article examines how modern targeted and immunotherapies are reshaping the role of allogeneic hematopoietic...

Continue ReadingThe Role of Allogeneic Hematopoietic Cell Transplantation in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.